Document Detail


Combination of sitaxentan and tadalafil for idiopathic pulmonary arterial hypertension following relapse on bosentan.
MedLine Citation:
PMID:  19171388     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sitaxentan, a highly-selective endothelin receptor antagonist (ETRA) and bosentan a non-selective ETRA are both approved for the treatment of idiopathic pulmonary arterial hypertension (iPAH). Sildenafil is a phosphodiesterase-5 (PDE-5) inhibitor used in the treatment of iPAH. Tadalafil is a long acting PDE-5 inhibitor largely unexplored for the treatment of iPAH. Following failure of monotherapy combination therapy with an ETRA and a PDE-5 inhibitor is often used, a frequently used combination being bosentan with sildenafil. We report our clinical experience in three patients with iPAH treated with a combination of sitaxentan and tadalafil, who previously discontinued bosentan. There was sustained symptomatic and haemodynamic improvement in all three patients treated with the combination. No adverse effect related to the combination treatment was noted. Sitaxentan and tadalafil, both being once a day treatments, can also possibly increase compliance.
Authors:
S Faruqi; H Fathi; A H Morice
Related Documents :
19885388 - Therapies for scleroderma-related pulmonary arterial hypertension.
16315058 - Generalized arterial calcification of infancy: two siblings with prolonged survival.
2632758 - Forearm vasodilatory capacity in patients with syndrome x: a comparison with normal and...
2190918 - 1989 corcoran lecture: adaptive and maladaptive responses of the arterial wall to hyper...
17366558 - Resistance and pulsatility index increase in capsular branches of testicular artery: in...
10639668 - The efficacy of ct arteriography for spinal arteriovenous fistula surgery: technical note.
Publication Detail:
Type:  Case Reports; Letter     Date:  2009-01-27
Journal Detail:
Title:  International journal of cardiology     Volume:  144     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-11     Completed Date:  2011-02-18     Revised Date:  2013-06-18    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  e43-5     Citation Subset:  IM    
Copyright Information:
Copyright © 2008 Elsevier Ireland Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antihypertensive Agents / therapeutic use*
Carbolines / therapeutic use*
Drug Therapy, Combination
Female
Humans
Hypertension, Pulmonary / drug therapy*,  physiopathology
Isoxazoles / therapeutic use*
Male
Middle Aged
Receptors, Endothelin / antagonists & inhibitors
Sulfonamides / therapeutic use*
Thiophenes / therapeutic use*
Treatment Outcome
Vasodilator Agents / therapeutic use
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Carbolines; 0/Isoxazoles; 0/Receptors, Endothelin; 0/Sulfonamides; 0/Thiophenes; 0/Vasodilator Agents; 0/sitaxsentan; 0/tadalafil; Q326023R30/bosentan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cannabis induced acute coronary syndrome in a young female.
Next Document:  Anomalous right coronary artery arising next to the left coronary ostium: unambiguous detection of t...